MOA: Massive Online Analysis, a framework for stream classification and clustering.

Massive Online Analysis (MOA) is a software environment for implementing algorithms and running experiments for online learning from evolving data streams. MOA is designed to deal with the challenging problem of scaling up the implementation of state of the art algorithms to real world dataset sizes. It contains collection of offline and online for both classification and clustering as well as tools for evaluation. In particular, for classification it implements boosting, bagging, and Hoeffding Trees, all with and without Naive Bayes classifiers at the leaves. For clustering, it implements StreamKM++, CluStream, ClusTree, Den-Stream, D-Stream and CobWeb. Researchers benefit from MOA by getting insights into workings and problems of different approaches, practitioners can easily apply and compare several algorithms to real world data set and settings. MOA supports bi-directional interaction with WEKA, the Waikato Environment for Knowledge Analysis, and is released under the GNU GPL license

Электроэнергетика в Японии

Статья посвящена исследованию специфики функционирования электроэнергетики в Японии. Рассмотрены основные виды генерации электроэнергии и особенности энергосистемы. Автором были проанализированы основные этапы реформирования электроэнергетической отрасли Японии, а также их последствия

Application of multivariate analysis in the processing of medical data

Medical data frequently represent multidimensional datasets as investigated factors and clinical and laboratory parameters coverage is huge. This research area is very important in terms of practical applications. We were given monthly lipid metabolism and hormonal status data of children (including children suffering from obesity) of Siberian region during a year. In this article some research results appear

Hydrothermal alteration mapping of Siberian gold-ore fields based on satellite spectroscopy data

The mapping of the hydrothermal alterations in Urjahskoe and Fedorov-Kedrov gold-ore fields was conducted by applying channel relationship method (band ratio) based on ASTER spectral-zonal satellite image data. It was determined that the calculated mineral indices in ore-bearing structures are zonal. Outer ore-bearing structures revealed increased ferric mineral index values, while inner - high epidote- chlorite- calcite and muscovite- siderite mineral index values. Detected regularities could be used in identifying potential gold-ore bearing areas within identical fields based on remote sensing survey data

Discovery of common and rare genetic risk variants for colorectal cancer.

To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 × 10-8, bringing the number of known independent signals for CRC to ~100. New signals implicate lower-frequency variants, Krüppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.Goncalo R Abecasis has received compensation from 23andMe and Helix. He is currently an employee of Regeneron Pharmaceuticals. Heather Hampel performs collaborative research with Ambry Genetics, InVitae Genetics, and Myriad Genetic Laboratories, Inc., is on the scientific advisory board for InVitae Genetics and Genome Medical, and has stock in Genome Medical. Rachel Pearlman has participated in collaborative funded research with Myriad Genetics Laboratories and Invitae Genetics but has no financial competitive interest

Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study

Background Early mobilisation (EM) is an intervention that may improve the outcome of critically ill patients. There is limited data on EM in COVID-19 patients and its use during the first pandemic wave. Methods This is a pre-planned subanalysis of the ESICM UNITE-COVID, an international multicenter observational study involving critically ill COVID-19 patients in the ICU between February 15th and May 15th, 2020. We analysed variables associated with the initiation of EM (within 72 h of ICU admission) and explored the impact of EM on mortality, ICU and hospital length of stay, as well as discharge location. Statistical analyses were done using (generalised) linear mixed-effect models and ANOVAs. Results Mobilisation data from 4190 patients from 280 ICUs in 45 countries were analysed. 1114 (26.6%) of these patients received mobilisation within 72 h after ICU admission; 3076 (73.4%) did not. In our analysis of factors associated with EM, mechanical ventilation at admission (OR 0.29; 95% CI 0.25, 0.35; p = 0.001), higher age (OR 0.99; 95% CI 0.98, 1.00; p ≤ 0.001), pre-existing asthma (OR 0.84; 95% CI 0.73, 0.98; p = 0.028), and pre-existing kidney disease (OR 0.84; 95% CI 0.71, 0.99; p = 0.036) were negatively associated with the initiation of EM. EM was associated with a higher chance of being discharged home (OR 1.31; 95% CI 1.08, 1.58; p = 0.007) but was not associated with length of stay in ICU (adj. difference 0.91 days; 95% CI − 0.47, 1.37, p = 0.34) and hospital (adj. difference 1.4 days; 95% CI − 0.62, 2.35, p = 0.24) or mortality (OR 0.88; 95% CI 0.7, 1.09, p = 0.24) when adjusted for covariates. Conclusions Our findings demonstrate that a quarter of COVID-19 patients received EM. There was no association found between EM in COVID-19 patients' ICU and hospital length of stay or mortality. However, EM in COVID-19 patients was associated with increased odds of being discharged home rather than to a care facility. Trial registration ClinicalTrials.gov: NCT04836065 (retrospectively registered April 8th 2021)